We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Commerzbk Uk Nt | LSE:97HF | London | Medium Term Loan |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0 | - |
Hot Features
Premium
RNS Number:9592V
Pharmagene PLC
18 December 2000
LETTER TO PHARMAGENE PLC
Notification of Disclosable Interest under S198 of the Companies Act
Further to the notification of Kleinwort Benson Group Limited on behalf of
Dresdner Bank AG dated 21 November 2000, Kleinwort Benson Holdings, Inc.
("KBH"), hereby advises you, pursuant to the above Act, the DrKB Life Science
Partner, L.P. ("LSP") holds the 4,427,089 ordinary 5p shares of Pharmagene plc
(or 8.75% of the issued ordinary shares of Pharmagene plc) which were the
subject of the prior disclosure.
This announcement is made on behalf of LSP by KBH, (an indirect, wholly-owned
subsidiary of Kleinwort Benson Limited), as the General Partner of DrKB General
Life Science Partners, L.P. which, in turn, is the General Partner of LSP, both
Delaware Limited Partnerships.
FROM KLEINWORT BENSON HOLDINGS INC
1 Year Commerzbk Uk Nt Chart |
1 Month Commerzbk Uk Nt Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
